Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.60606 | 59 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.58222 | 60 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.55332 | 59 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.85961 | 64 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.51167 | 59 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.57597 | 58 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.61104 | 59 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.54371 | 59 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.54658 | 59 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.55257 | 60 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.25344 | 69 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.55315 | 60 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.57525 | 59 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.07321 | 67 |